Skip to main content
Tags: poll | congress | drug prices | deficit

Poll: Congress Should Focus on High Drug Prices, Federal Deficit

capitol dome
(Getty Images)

By    |   Thursday, 03 January 2019 08:59 AM EST

The new Congress ought to focus on lowering drug prices and reducing the federal deficit, American voters said in a new poll from Politico and Harvard University.

"The top two issues were not top two issues in the election,” said Robert Blendon, the Richard L. Menschel Professor of Public Health and professor of health policy and political analysis at Harvard’s T.H. Chan School of Public Health and Kennedy School of Government. “So you've had a shift from what really drove voters to a somewhat different agenda.”

Blendon helped to design the survey, which shows that 80 percent of respondents, 90 percent of Democrats and 82 percent of Republicans, think it’s extremely important that Congress take action to lower the price of prescription medication. That same about, 80 percent, said working to reduce the federal deficit is also extremely important.

"The deficit would open up a battle that is just very hard," Blendon said. "Republicans lean on entitlements; Democrats will never go there."

Republicans and Democrats also continue to disagree about President Donald Trump and investigations into his finances and ties to Russia. About 58 percent of respondents said Congress should investigate Trump’s taxes and investments, while 62 percent believe that special counsel Robert Mueller’s investigation should continue. Both of these are widely supported by Democrats, but mostly opposed by Republicans.

The Politico-Harvard poll surveyed 1,014 adults from December 4-9, and has a margin of error between +/- 3.6 and 5.1 percentage points.

© 2025 Newsmax. All rights reserved.


Newsfront
Voters in a new poll say the new Congress ought to focus on lowering drug prices and reducing the federal deficit.
poll, congress, drug prices, deficit
242
2019-59-03
Thursday, 03 January 2019 08:59 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the Newsmax App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved